About Indus Pharma
Indus Pharma is a company based in Delhi (India) founded in 1974. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. The company has 46 employees. Indus Pharma offers products and services including Antibiotics, Critical Care Medicine, and Rare Disease Treatments.
- Headquarter Delhi, India
- Employees 46
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website induspharmaindia.com
- Social Facebook
- Legal Name Indus Pharma Pvt Ltd
- Date of Incorporation 12 Jan, 1987
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹28.11 Cr
FY 2023 · -58% YoY
- Net Profit₹1.66 Cr
FY 2023 · 6% margin
- EBITDA₹4.53 Cr
FY 2023 · 16% margin
- Employee Count46
Associated legal entities of Indus Pharma
Indus Pharma operates through Indus Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indus Pharma Private Limited CIN U74899DL1987PTC026657 | Active | 12 Jan 1987 | New Delhi, Delhi | ₹28.1 Cr | 46 | 3 | View details |
Products & Services of Indus Pharma
Indus Pharma offers a comprehensive portfolio of products and services, including Antibiotics, Critical Care Medicine, and Rare Disease Treatments.
Antibiotics are developed to combat resistant infectious pathogens.
Life-saving medications are created for emergency care situations.
Treatments are pioneered for orphan diseases affecting few.
Board of directors of Indus Pharma Private Limited (Indus Pharma)
Indus Pharma Private Limited is the primary company behind Indus Pharma. The board of Indus Pharma Private Limited currently have 3 directors; the longest-serving is Radhey Shyam Arora, appointed in 1987. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Radhey Shyam Arora DIN 00214526 | Managing Director | 12 Jan 1987 | 39 yrs 8 mo | Indus Pharma Private Limited |
| Surinder Arora DIN 07210631 | Director | 15 Jun 2016 | 10 yrs 3 mo | Indus Pharma Private Limited |
| Mukta Arora DIN 07210622 | Director | 15 Jun 2016 | 10 yrs 3 mo | Indus Pharma Private Limited |
Financials of Indus Pharma
Figures of Indus Pharma Private Limited, the primary company behind Indus Pharma, for FY 2023. Revenue was ₹28.11 Cr (-58% year on year). Net profit was ₹1.66 Cr (6% margin). EBITDA was ₹4.53 Cr (16% margin). Revenue has grown at a compounded annual rate of -8% over three years and 0% over five years.
- ₹28.11 CrRevenue · FY 2023 · -58% YoY
- ₹1.66 CrNet profit · 6% margin
- ₹4.53 CrEBITDA · 16% margin
- ₹20 LakhPaid-up capital
- 46Employees (provident fund records)
- -8%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indus Pharma Private Limited are on its company page.
Detailed financial statements for Indus Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Indus Pharma
10 companies that operate in the same segment as Indus Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Indus Pharma
Indus Pharma was founded in 1974.
Indus Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Indus Pharma has 46 employees.
The primary company behind Indus Pharma, Indus Pharma Private Limited, reported revenue of ₹28.11 Cr for FY 2023, down 58% year on year.
Indus Pharma is focused on the development and manufacturing of advanced pharmaceutical solutions to address global healthcare challenges. The company operates in sectors such as infectious diseases, critical care, rare diseases, and global health access. State-of-the-art facilities and rigorous quality standards are maintained to ensure patient safety and efficacy. Solutions are provided for underserved populations by making essential medicines accessible and affordable. Innovation is driven through research and development to tackle complex medical needs worldwide.
Indus Pharma offers Antibiotics, Critical Care Medicine, and Rare Disease Treatments.
Indus Pharma operates through Indus Pharma Private Limited.
The legal entities of Indus Pharma currently have 3 directors, including Radhey Shyam Arora, Surinder Arora, Mukta Arora.